Keyphrases
Advanced Prostate Cancer
12%
Androgen Deprivation Therapy
18%
Antiandrogen
12%
Better Prognosis
6%
Biopsy Tissue
6%
Cancer Inpatients
6%
Cancer Stem Cell Markers
6%
Castration-resistant Prostate Cancer
100%
CD133
31%
CD133 Protein
100%
CD44 Protein
100%
Cluster of Differentiation 44 (CD44)
37%
Confidence Interval
6%
Delayed Diagnosis
6%
H-score
6%
High-level Expression
6%
Immunohistochemical Staining
6%
Inclusion Criteria
6%
LHRH Agonist
6%
Low Expression
12%
No Significant Difference
6%
Odds Ratio
6%
Patient-centered
6%
Patients with Prostate Cancer
6%
Prognostic Factors
100%
Prognostic Marker
6%
Prostate Biopsy
6%
Prostate Cancer
12%
Prostate Carcinoma
6%
Prostate Tumor Cells
6%
Protein Expression
100%
Retrospective Case-Control Design
6%
Score Differences
6%
Tissue Sampling
6%
Neuroscience
Androgen
18%
Antiandrogen
12%
Cancer Stem Cell
12%
CD133
100%
CD44
100%
Gonadotropin-Releasing Hormone Agonist
6%
Histopathology
6%
Prostate
100%
Protein Expression
100%
Staining Technique
6%
Medicine and Dentistry
Androgen Deprivation Therapy
18%
Antiandrogen
12%
Cancer Stem Cell
12%
Case-Control Study
6%
Castration Resistant Prostate Cancer
100%
Cell Marker
6%
Gonadorelin Agonist
6%
Histopathology
6%
Odds Ratio
6%
Prognostic Factor
100%
Prostate Adenocarcinoma
6%
Prostate Biopsy
6%
Prostate Cancer
31%
Protein Expression
100%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
18%
Antiandrogen
12%
Case-Control Study
6%
Castration Resistant Prostate Cancer
100%
Cell Marker
6%
Gonadorelin Agonist
6%
Malignant Neoplasm
6%
Prostate Adenocarcinoma
6%
Prostate Cancer
31%